Severe hypertension in pregnancy.


Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 11 9 2021
pubmed: 12 9 2021
medline: 24 9 2021
Statut: ppublish

Résumé

Severe hypertension in pregnancy is defined as a sustained systolic blood pressure of 160 mmHg or over or diastolic blood pressure of 110 mmHg or over and should be assessed in hospital. Severe hypertension before 20 weeks' gestation is rare and usually due to chronic hypertension; assessment for target organ damage and exclusion of secondary hypertension are warranted. The most common cause of severe hypertension in pregnancy is pre-eclampsia, which presents after 20 weeks' gestation. This warrants more rapid control of blood pressure due to the risk of haemorrhagic stroke, and intravenous antihypertensive agents may be required. Treatment is determined by licensing, availability and clinician experience, with no high-level evidence to guide prescribing. Labetalol is the agent most commonly used, both orally and intravenously, in pregnancy in the UK. Severe hypertension is a risk factor for sustained hypertension after pregnancy. Hypertension in pregnancy is associated with increased cardiovascular risk.

Identifiants

pubmed: 34507929
pii: 21/5/e451
doi: 10.7861/clinmed.2021-0508
pmc: PMC8439512
doi:

Substances chimiques

Antihypertensive Agents 0
Labetalol R5H8897N95

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e451-e456

Informations de copyright

© Royal College of Physicians 2021. All rights reserved.

Références

Am J Obstet Gynecol. 2022 Feb;226(2S):S819-S834
pubmed: 32882208
BMC Nephrol. 2019 Oct 31;20(1):401
pubmed: 31672135
Hypertension. 2016 Nov;68(5):1153-1159
pubmed: 27620393
Obstet Gynecol. 2020 Mar;135(3):653-664
pubmed: 32028507
Eur J Clin Pharmacol. 1990;38(1):99
pubmed: 2158450
Cochrane Database Syst Rev. 2018 Oct 01;10:CD002252
pubmed: 30277556
Am J Kidney Dis. 2017 Apr;69(4):498-505
pubmed: 27707553
BMJ. 2019 Sep 9;366:l5119
pubmed: 31501137
BMJ. 2013 Feb 25;346:f894
pubmed: 23440270
Am J Obstet Gynecol. 2002 Jan;186(1):66-71
pubmed: 11810087
Obstet Gynecol. 2005 Feb;105(2):246-54
pubmed: 15684147
Hypertension. 2018 Jul;72(1):24-43
pubmed: 29899139
Hypertension. 2020 Dec;76(6):1828-1837
pubmed: 33012200
Kidney Int Rep. 2018 Oct 29;4(3):408-419
pubmed: 30899868
Obstet Gynecol. 2000 Jan;95(1):24-8
pubmed: 10636496
Hypertension. 2019 Mar;73(3):522-531
pubmed: 30712425
N Engl J Med. 2015 Jan 29;372(5):407-17
pubmed: 25629739

Auteurs

Kate Wiles (K)

The Royal London Hospital, London, UK kate.wiles@nhs.net.

Mellisa Damodaram (M)

Queen Charlotte's and Chelsea Hospital, London, UK.

Charlotte Frise (C)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK and Queen Charlotte's and Chelsea Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH